Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $456 | $9,970 | $13,928 | $18,737 |
| - Cash | $8 | $2,021 | $10 | $357 |
| + Debt | $2,892 | $2,544 | $1,950 | $1,339 |
| Enterprise Value | $3,340 | $10,493 | $15,867 | $19,719 |
| Revenue | $8,635 | $10,986 | $10,925 | $9,543 |
| % Growth | -21.4% | 0.6% | 14.5% | – |
| Gross Profit | $1,406 | $2,577 | $3,172 | $2,176 |
| % Margin | 16.3% | 23.5% | 29% | 22.8% |
| EBITDA | $42 | $1,957 | -$694 | $1,221 |
| % Margin | 0.5% | 17.8% | -6.4% | 12.8% |
| Net Income | -$5,091 | $311 | -$2,246 | $391 |
| % Margin | -59% | 2.8% | -20.6% | 4.1% |
| EPS Diluted | -0.22 | 0.01 | -0.12 | 0.02 |
| % Growth | -2,300% | 108.3% | -700% | – |
| Operating Cash Flow | -$122 | $1,836 | -$991 | -$540 |
| Capital Expenditures | $4 | $35 | -$39 | $0 |
| Free Cash Flow | -$118 | $1,871 | -$1,030 | -$540 |